MedPath
NMPA Approval

Eribulin Mesilate Injection

H20190042

July 12, 2019

Drug Information

甲磺酸艾立布林注射液

海乐卫

注射剂

2ml:1mg

化学药品

July 12, 2019

July 11, 2024

Company Information

Applicant Company

Eisai Europe Ltd

European Knowledge Centre, Mosquito Way, Hatfield, Hertfordshire AL10 9SN, United Kingdom

Manufacturing Company

Via Appia Km 65,561 (loc. Latina Scalo), 04013 Latina (LT), Italy

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲磺酸艾立布林注射液 - NMPA 批准文号 | MedPath